Page last updated: 2024-10-30

leflunomide and Symptom Cluster

leflunomide has been researched along with Symptom Cluster in 2 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vaish, AK1
Tripathi, AK1
Gupta, LK1
Jain, N1
Agarwal, A1
Verma, SK1
Gregory, CR1
Stewart, A1
Sturges, B1
DeManvelle, T1
Cannon, A1
Ortega, T1
Harb, M1
Morris, RE1

Other Studies

2 other studies available for leflunomide and Symptom Cluster

ArticleYear
An unusual case of DRESS syndrome due to leflunomide.
    BMJ case reports, 2011, Sep-04, Volume: 2011

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Candidiasis, Oral; Diagnosis, Differential; Drug Eru

2011
Leflunomide effectively treats naturally occurring immune-mediated and inflammatory diseases of dogs that are unresponsive to conventional therapy.
    Transplantation proceedings, 1998, Volume: 30, Issue:8

    Topics: Aniline Compounds; Animals; Crotonates; Dog Diseases; Dogs; Female; Hydroxybutyrates; Immune System

1998